The Experts below are selected from a list of 1200 Experts worldwide ranked by ideXlab platform

Andreas Stein - One of the best experts on this subject based on the ideXlab platform.

Estelle Honnorat - One of the best experts on this subject based on the ideXlab platform.

Marian Zembala - One of the best experts on this subject based on the ideXlab platform.

  • Transcatheter Closure of Postinfarction Ventricular Septal Defects Using Amplatzer Devices
    Revista espanola de cardiologia, 2007
    Co-Authors: Jacek Białkowski, Małgorzata Szkutnik, Jacek Kusa, Zbigniew Kalarus, Mariusz Gasior, Roman Przybylski, Paweł Banaszak, Marian Zembala
    Abstract:

    We carried out transcatheter procedures to close postinfarction ventricular Septal defects (PIVSDs) in 19 patients: two had recanalization after surgical closure, and 17 had a primary PIVSD. In three of the latter patients, who had acute PIVSDs, the procedure was carried out in the first 3 weeks after infarction; in the 13 patients with subacute PIVSD, it was carried out 3.5–12 weeks after infarction. There was another procedure in one patient with chronic PIVSD. In total, 22 procedures were completed: 17 using an Amplatzer Atrial Septal Occluder, 2 using an Amplatzer postinfarction ventricular Septal defect Occluder, and 2 using an Amplatzer muscular ventricular Septal defect Occluder. The procedure was successful in 14 patients: in 11 with subacute PIVSD, one with chronic PIVSD, and 2 with postsurgical PIVSD. Transcatheter closure of PIVSDs using an Amplatzer Atrial Septal Occluder is probably the treatment of choice in patients undergoing surgery more than 3.5 weeks after myocardial infarction and in those with recanalization after previous surgical closure.

  • Transcatheter closure of Atrial Septal defects in adults with the Amplatzer Atrial Septal Occluder
    Polskie Archiwum Medycyny Wewnetrznej, 2001
    Co-Authors: J. Bialkowski, Małgorzata Szkutnik, Krzysztof Wilczek, B. Chodor, B. Zeifert, Jacek Sikora, K Szatkowski, I Haponiuk, Marian Zembala
    Abstract:

    UNLABELLED In many centres the Amplatzer Septal Occluder (ASO) (AGA Med. Corp. Minnesota, USA) has become the device of choice for secundum Atrial Septal defect (ASD) closure in children. Current trend towards transcatheter closure of ASD in children could be translated to adults and many patients (pts) may avoid the need of open heart surgery. Assessment the efficacy and complication of device occlusion of ASD in adults, using ASO. Between October 1997 and April 2001 transcatheter closure of ASD was attempted in 51 pts who fulfilled the inclusion criteria--significant shunt with sufficient rims of interAtrial septum. Mean age of pts was 29 (16-63) y, mean ASD diameter assessed by transesophageal echocardiography (TEE) was 14.7 (7-24) mm, assessed during catheterization by balloon sizing (stretched diameter) was 20.2 (8-36) mm. There were 9 pts with multiple ASDs, 2 pts with aneurysm of interAtrial septum and 2--after previous surgery (recanalization of ASD). The ASO devices were successfully implanted in all, but one pt. In one patient because of unstable position of ASO (floppy rims), device was removed and bigger one was applied during next session. In one case early embolization to abdominal aorta occurred, ASO was translocated to aortic arch with Dotter basket and removed from aorta during simultaneous surgical closure of ASD. Mean fluoroscopy time was 15 (4-50) min. The occlusion rate after 24 h was 90%, after 1 month (m) 92%, after 3 m 93.5%, after 1 year (y) 93.3% and after 2 y 93.3%. All residual shunts were trivial. There were no late complication. CONCLUSIONS The excellent results of ASD closure with ASO in adults indicate this treatment as a method of choice in selected patients, but long term follow-up is necessary to state final judgement.

Alberto Riberi - One of the best experts on this subject based on the ideXlab platform.

Gilbert Habib - One of the best experts on this subject based on the ideXlab platform.